OncoLens

Series-B+
oncolens.com Biotech & Healthcare Atlanta, United States
Total Funding $24.6M
Latest Round $16M Series-B+
Last Announced Oct 24, 2024
Investors 6 Backers
Decision Makers 5 Verified

About OncoLens

OncoLens is the multidisciplinary cancer care platform for tumor boards, registry automation, AI patient identification, and oncology analytics.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Atlanta, United States
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website oncolens.com
Domain Registered Date Jun 25, 2015

Social & Network Presence

X / Twitter Profile @OncoLens (455 followers) Created on Mar 2017
LinkedIn Corporate Not linked

Company Milestones & Timeline

5 Events
  1. Capital Raise

    Raised $16,000,000 · Series-B+

    startupintros.com

  2. Capital Raise

    Raised $7,250,000 · Series-A

    startupintros.com

  3. Capital Raise

    Raised $1,350,000 · Seed

    startupintros.com

  4. Milestone

    X account created (@OncoLens)

    455 followers

  5. Milestone

    Website domain registered

    oncolens.com

Investors & Backers

6
Atlanta Technology Angels
BIP Capital
Cross-Border Impact Ventures
Martin Ventures
Robbins Fund
SeedToB Capital

Funding History

3 Rounds
Series-B+ · Oct 24, 2024
Series-A · Jan 13, 2021
Seed · Mar 26, 2019

Founders & Leadership

3

Anju Mathew

Co-founder and Chief Executive Officer

Work email & phone locked Unlock →

Keith Anderson

Director of Talent - Fractional

Work email & phone locked Unlock →

Lijo Simpson

Co-founder and Chief Medical Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts